These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16037517)

  • 21. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
    Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
    J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
    Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.
    Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
    Cancer; 2007 Oct; 110(8):1738-44. PubMed ID: 17786947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is FDG-PET indicated for superficial esophageal cancer?
    Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
    Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    Hoang JK; Hoagland LF; Coleman RE; Coan AD; Herndon JE; Patz EF
    J Clin Oncol; 2008 Mar; 26(9):1459-64. PubMed ID: 18349396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography in the staging of esophageal cancer.
    Leccisotti L
    Rays; 2006; 31(1):9-12. PubMed ID: 16999368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S; Penney BC; Zhang H; Suzuki K; Pu Y
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
    de Jong WK; van der Heijden HF; Pruim J; Dalesio O; Oyen WJ; Groen HJ
    J Thorac Oncol; 2007 Nov; 2(11):1007-12. PubMed ID: 17975491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer.
    Song SY; Kim JH; Ryu JS; Lee GH; Kim SB; Park SI; Song HY; Cho KJ; Ahn SD; Lee SW; Shin SS; Choi EK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1053-9. PubMed ID: 15964705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2006 Aug; 82(2):391-4; discussion 394-5. PubMed ID: 16863735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Was [¹⁸F]fluorodeoxyglucose positron emission tomography complete response after chemoradiotherapy defined as standardized uptake value(max-1 hour) ≤ 3 complete?
    Ma W; Wang J; Yang W; Li G; Wang S
    J Clin Oncol; 2011 Mar; 29(9):e248; author reply e249-50. PubMed ID: 21282534
    [No Abstract]   [Full Text] [Related]  

  • 34. FDG-PET parameters as prognostic factor in esophageal cancer patients: a review.
    Omloo JM; van Heijl M; Hoekstra OS; van Berge Henegouwen MI; van Lanschot JJ; Sloof GW
    Ann Surg Oncol; 2011 Nov; 18(12):3338-52. PubMed ID: 21537872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
    Machtay M; Natwa M; Andrel J; Hyslop T; Anne PR; Lavarino J; Intenzo CM; Keane W
    Head Neck; 2009 Feb; 31(2):195-201. PubMed ID: 19107945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal fluorine-18-fluorodeoxyglucose uptake in benign esophageal leiomyoma.
    Miyoshi K; Naito M; Ueno T; Hato S; Ino H
    Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):629-32. PubMed ID: 19908121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma.
    Makino T; Miyata H; Yamasaki M; Fujiwara Y; Takiguchi S; Nakajima K; Higuchi I; Hatazawa J; Mori M; Doki Y
    Surgery; 2010 Nov; 148(5):908-18. PubMed ID: 20378140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F-18-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer.
    Schmidt M; Bollschweiler E; Hölscher A
    Ann Surg; 2010 Aug; 252(2):412-3; author reply 413. PubMed ID: 20647915
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of ROI definition, partial volume correction and SUV normalization on SUV-survival correlation in oesophageal cancer.
    van Heijl M; Omloo JM; van Berge Henegouwen MI; van Lanschot JJ; Sloof GW; Boellaard R
    Nucl Med Commun; 2010 Jul; 31(7):652-8. PubMed ID: 20545013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (18)F-FDG accumulations in primary malignant melanoma of the esophagus.
    Okano K; Sugiyama T; Akamoto S; Yachida S; Usuki H; Wakabayashi H; Maeta H
    Surgery; 2006 Jul; 140(1):118-9. PubMed ID: 16857450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.